7-141778505-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_016944.2(TAS2R4):āc.17A>Gā(p.Tyr6Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,460,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016944.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R4 | NM_016944.2 | c.17A>G | p.Tyr6Cys | missense_variant | 1/1 | ENST00000247881.4 | NP_058640.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R4 | ENST00000247881.4 | c.17A>G | p.Tyr6Cys | missense_variant | 1/1 | 6 | NM_016944.2 | ENSP00000247881.3 | ||
SSBP1 | ENST00000465582.5 | c.*31-9218A>G | intron_variant | 5 | ENSP00000420485.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 250388Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135352
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1460170Hom.: 0 Cov.: 29 AF XY: 0.0000151 AC XY: 11AN XY: 726312
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2023 | The c.17A>G (p.Y6C) alteration is located in exon 1 (coding exon 1) of the TAS2R4 gene. This alteration results from a A to G substitution at nucleotide position 17, causing the tyrosine (Y) at amino acid position 6 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at